Hillenbrand First-Quarter Revenue Increased 26% to $385 Million

Posted by: Hillenbrand  | Tuesday, February 4, 2014 11:47 am

BATESVILLE, Ind., Feb. 4, 2014 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: HI) reported results today for the first quarter ended December 31, 2013. Revenue was $385 million, representing 26% growth over the prior year. The Process Equipment Group reported revenue of $242 million, a 58% increase due primarily to the acquisition of Coperion in December 2012, and order backlog of $611 million, a 1% increase from September 30, 2013. Batesville revenue was $143 million, a 6% decrease driven by a lower number of North American burials.

"We continue to be encouraged by order activity throughout the Process Equipment Group, with backlog once again at a record-high level. Given our visibility into backlog, we expect mid-single-digit revenue growth for this group for the year," said Joe A. Raver, President and Chief Executive Officer of Hillenbrand. "Batesville delivered a solid performance this quarter, with improved margins despite reduced volume. We expect a similar volume decrease in the second quarter, as pneumonia and influenza are expected to have less of an impact on the number of deaths this year than they did last year."

Hillenbrand reports results on a GAAP and adjusted basis. Adjusted measures are reconciled to the corresponding GAAP measures at the end of this release. Net income increased 42% to $20 million ($0.32 per diluted share) primarily due to lower Coperion acquisition-related costs. On an adjusted basis, net income decreased 15% to $22 million ($0.34 per diluted share) driven primarily by lower revenue at Batesville. Adjusted EBITDA increased 4% to $53 million and operating cash flow was up $26 million to $46 million.

"Our growth strategy has transformed Hillenbrand into a global diversified industrial company," said Raver. "We have made substantial investments over the past three years and believe we are well-positioned to deliver long-term growth and value for our shareholders."

    Conference Call Information

    Date/Time:                   8:00 a.m. EST, Wednesday, February 5, 2014

    Dial-In for U.S. and Canada: 1-877-853-5642

    Dial-In for International:   +1-253-237-1134

    Conference call ID number:                                                  50525720

    Webcast link:                 http://ir.hillenbrand.com (archived through Wednesday,
                                  March 5, 2014)


    Replay - Conference Call

    Date/Time:                    Available until midnight EST, Wednesday, February 19,
                                  2014

    Dial-In for U.S. and Canada: 1-855-859-2056

    Dial-In for International:   +1-404-537-3406

    Conference call ID number:                                                  50525720

Hillenbrand's interim financial statements on Form 10-Q are expected to be filed jointly with this release and will be available on the Company's website (www.Hillenbrand.com).

In addition to the financial measures prepared in accordance with accounting principles generally accepted in the U.S. (GAAP), this earnings release also contains non-GAAP operating performance measures. These non-GAAP measures are referred to as "adjusted" and exclude expenses associated with backlog amortization, inventory step-up, business acquisitions and integration, restructuring, and antitrust litigation. The related income tax for all of these items is also excluded. This non-GAAP information is provided as a supplement, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

An important non-GAAP measure Hillenbrand uses is adjusted earnings before interest, income tax, depreciation, and amortization ("adjusted EBITDA"). As previously discussed, a part of Hillenbrand's strategy is to selectively acquire companies that we believe can benefit from our core competencies to spur faster and more profitable growth. Given that strategy, it is a natural consequence to incur related expenses, such as amortization from acquired intangible assets and additional interest expense from debt-funded acquisitions. Accordingly, we use adjusted EBITDA, among other measures, to monitor business performance.

Hillenbrand uses this non-GAAP information internally to make operating decisions and believes it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by these types of items. Finally, Hillenbrand believes this information provides a higher degree of transparency.

See below for a reconciliation from GAAP operating performance measures to the relevant non-GAAP (adjusted) performance measures.

Hillenbrand (www.Hillenbrand.com) is a global diversified industrial company that makes and sells premium business-to-business products and services for a wide variety of industries. We pursue profitable growth and meaningful dividends for our shareholders by leveraging our leading brands, robust cash generation capabilities, and strong core competencies. HI-INC-F


    Consolidated Statements of Income
    (in millions, except per share data)


                                            Three Months Ended

                                               December 31,
                                               ------------

                                         2013                         2012
                                         ----                         ----


    Net revenue                                               $384.9        $305.2

    Cost of goods sold                                         253.9         194.7
                                                               -----         -----

           Gross profit                                        131.0         110.5

    Operating expenses                                          94.0          86.4
                                                                ----          ----

           Operating profit                                     37.0          24.1

    Interest expense                                             6.3           4.5

    Other income (expense),
     net                                                        (0.1)          0.9
                                                                ----           ---

           Income before income
            taxes                                               30.6          20.5

    Income tax expense                                           9.0           5.9
                                                                 ---           ---

          Consolidated net income                               21.6          14.6

    Less: Net income
     attributable to
     noncontrolling interests                                    1.3           0.3
                                                                 ---           ---

         Net income(1)                                         $20.3         $14.3
                                                               =====         =====


    Net income(1) per share
     of common stock:

    Basic earnings per share                                   $0.32         $0.23

    Diluted earnings per
     share                                                     $0.32         $0.23

    Weighted-average shares
     outstanding - basic                                        63.1          62.4

    Weighted-average shares
     outstanding - diluted                                      63.7          62.6


    Cash dividends per share                                 $0.1975       $0.1950


    (1)Net income
     attributable to
     Hillenbrand

    Condensed Consolidated Statements of Cash Flow
    (in millions)


                                                    Three Months Ended

                                                       December 31,
                                                       ------------

                                                   2013                2012
                                                   ----                ----

    Net cash provided by
     operating activities                                  $45.9             $19.7

    Net cash used in
     investing activities                                   (6.2)           (418.6)

    Net cash (used in)
     provided by financing
     activities                                            (19.3)            480.0

    Effect of exchange rate
     changes on cash and
     cash equivalents                                       (0.8)              0.8
                                                            ----               ---

    Net cash flow                                           19.6              81.9


    Cash and cash
     equivalents:

    At beginning of period                                  42.7              20.2

    At end of period                                       $62.3            $102.1
                                                           =====            ======



    Reconciliation of Non-GAAP Measures
    (in millions, except per share data)


                                                                  Three Months Ended December 31,
                                                                  -------------------------------

                                                                      2013                                               2012
                                                                      ----                                               ----

                                         GAAP         Adjustments                   Adjusted         GAAP         Adjustments Adjusted
                                         ----         -----------                   --------         ----         ----------- --------

    Cost of goods sold                        $253.9                     $                (0.1) (a)       $253.8                $194.7  $  (3.0) (d)  $191.7

    Operating expenses                          94.0                                      (2.1) (b)         91.9                  86.4    (13.6) (e)    72.8

    Other income                                (0.1)                                             -         (0.1)                  0.9                     -

    (expense), net                                                                                                                         (0.9) (f)

    Income tax expense                           9.0                                        0.6 (c)          9.6                   5.9       4.2 (c)    10.1

    Net income(1)                               20.3                                            1.6         21.9                  14.3          11.5    25.8

    Diluted EPS                                 0.32                                           0.02         0.34                  0.23          0.18    0.41


    Ratios:

    Gross margin                                34.0%                                           0.1%        34.1%                 36.2%          1.0%   37.2%

    Operating expenses                          24.4%                                         (0.5)%        23.9%                 28.3%        (4.4)%   23.9%

    as a % of revenue
                                                                                                                                                    
                                                                                                                                                                                        
    Both GAAP and adjusted results for the three months ended December 31, 2013, include an adjustment to operating expenses to correct
     errors related to the accounting for sales commissions at Coperion in fiscal 2013.  The adjustment reduced operating expenses in the
     first quarter of fiscal 2014 by $2.0, which should have been recorded in fiscal 2013.
                                                                                                                                                                                        
                                                                                                                                                                                        
    1 Net income attributable to Hillenbrand
                                                                                                                                                                                        
                                                                                                                                                                                        
    P = Process Equipment Group; B = Batesville; C = Corporate
                                                                                                                                                                                       
    (a) Restructuring ($0.1 B)
                                                                                                                                                                                       
    (b) Business acquisition and integration costs ($0.7 P, $1.2 C), restructuring ($0.2 P)
                                                                                                                                                                                       
    (c) Tax effect of adjustments
                                                                                                                                                                                       
    (d) Inventory step up ($2.6 P), restructuring ($0.1 P, $0.3 B)
                                                                                                                                                                                       
    (e) Business acquisition and integration costs ($9.0 C), backlog amortization ($4.2 P), restructuring ($0.2 C),
                                                                                                                                                                                       
    antitrust litigation ($0.1 B), other ($0.1 B)
                                                                                                                                                                                       
    (f) Acquisition-related foreign currency transactions ($0.8 C), other ($0.1 B)
                                                                                                                                                                                       
                                                                                                                                                                                                          

                                                                                                                                                                                          
                                                                                                                                             Three Months Ended
                                                                                                                                                                                          
                                                                                                                                                December 31,
                                                                                                                                                ------------
                                                                                                                                                                                                   
                                                                                                                                           2013                                   2012
                                                                                                                                           ----                                   ----
                                                                                                                                                                                                 
    Net income of consolidated and affiliated
                                                                                                                                                                                                 
                                                                                                                             $21.6                                             $14.6
                                                                                                                                                                                                 
    subsidiaries
                                                                                                                                                                                                 
                                                                                                                              (0.2)                                             (0.1)
                                                                                                                                                                                                 
    Interest income
                                                                                                                                                                                                 
                                                                                                                               6.3                                               4.5
                                                                                                                                                                                                 
    Interest expense
                                                                                                                                                                                                 
                                                                                                                               9.0                                               5.9
                                                                                                                                                                                                 
    Income tax expense
                                                                                                                                                                                                 
                                                                                                                              14.3                                              15.0
                                                                                                                                                                                                 
    Depreciation and amortization
                                                                                                                                                                                                 
                                                                                                                                                                                                 
    EBITDA                                                                                                                   $51.0                                             $39.9
                                                                                                                                                                                                 
                                                                                                                               1.9                                               8.2
                                                                                                                                                                                                 
    Business acquisition and integration
                                                                                                                                                                                                 
                                                                                                                                 -                                               2.6
                                                                                                                                                                                                 
    Inventory step-up
                                                                                                                                                                                                 
                                                                                                                               0.3                                               0.6
                                                                                                                                                                                                 
    Restructuring
                                                                                                                                                                                                 
                                                                                                                                 -                                               0.1
                                                                                                                                                                                                 
    Antitrust litigation
                                                                                                                                                                                                 
                                                                                                                                                                                                 
    EBITDA - adjusted                                                                                                        $53.2                                             $51.4
                                                                                                                             =====                                             =====
                                                                                                                                                                                                 

Throughout this release, we make a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. As the words imply, forward-looking statements are statements about the future, as contrasted with historical information. Our forward-looking statements are based on assumptions and current expectations of future events that we believe are reasonable, but by their very nature they are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand's expectations and projections.

Words that could indicate that we are making forward-looking statements include the following:

    intend   believe   plan     expect  may      goal      would

    become   pursue    estimate will    forecast continue  could

    targeted encourage promise  improve progress potential should

This is not an exhaustive list. Our intent is to provide examples of how readers might identify forward-looking statements. The absence of any of these words, however, does not mean that the statement is not forward-looking.

Here is the key point: Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. These factors include, but are not limited to: the outcome of any legal proceedings that may be instituted against Hillenbrand, or any companies we may acquire; risks that an acquisition disrupts current operations or poses potential difficulties in employee retention or otherwise affects financial or operating results; the ability to recognize the benefits of an acquisition, including potential synergies and cost savings or the failure of an acquired company to achieve its plans and objectives generally; global market and economic conditions, including those related to the credit markets; volatility of our investment portfolio; adverse foreign currency fluctuations; ongoing involvement in claims, lawsuits and governmental proceedings related to operations; labor disruptions; the dependence of our business units on relationships with several large providers; increased costs or unavailability of raw materials; continued fluctuations in mortality rates and increased cremations; competition from nontraditional sources in the death care industry; cyclical demand for industrial capital goods; and certain tax-related matters. For a more in-depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in Part II, Item 1A of Hillenbrand's Form 10-Q for the quarter ended December 31, 2013, filed with the Securities and Exchange Commission on February 4, 2014. The company assumes no obligation to update or revise any forward-looking information.

SOURCE Hillenbrand, Inc.

SOURCE: Hillenbrand, Inc.

Hillenbrand First-Quarter Revenue Increased 26% to $385 Million

-- Process Equipment Group revenue increased 58% to $242 million

-- Order backlog increased to $611 million

PR Newswire

BATESVILLE, Ind., Feb. 4, 2014 /PRNewswire/ -- Hillenbrand, Inc. (NYSE: HI) reported results today for the first quarter ended December 31, 2013. Revenue was $385 million, representing 26% growth over the prior year. The Process Equipment Group reported revenue of $242 million, a 58% increase due primarily to the acquisition of Coperion in December 2012, and order backlog of $611 million, a 1% increase from September 30, 2013. Batesville revenue was $143 million, a 6% decrease driven by a lower number of North American burials.

"We continue to be encouraged by order activity throughout the Process Equipment Group, with backlog once again at a record-high level. Given our visibility into backlog, we expect mid-single-digit revenue growth for this group for the year," said Joe A. Raver, President and Chief Executive Officer of Hillenbrand. "Batesville delivered a solid performance this quarter, with improved margins despite reduced volume. We expect a similar volume decrease in the second quarter, as pneumonia and influenza are expected to have less of an impact on the number of deaths this year than they did last year."

Hillenbrand reports results on a GAAP and adjusted basis. Adjusted measures are reconciled to the corresponding GAAP measures at the end of this release. Net income increased 42% to $20 million ($0.32 per diluted share) primarily due to lower Coperion acquisition-related costs. On an adjusted basis, net income decreased 15% to $22 million ($0.34 per diluted share) driven primarily by lower revenue at Batesville. Adjusted EBITDA increased 4% to $53 million and operating cash flow was up $26 million to $46 million.

"Our growth strategy has transformed Hillenbrand into a global diversified industrial company," said Raver. "We have made substantial investments over the past three years and believe we are well-positioned to deliver long-term growth and value for our shareholders."

Conference Call Information

Date/Time:

8:00 a.m. EST, Wednesday, February 5, 2014

Dial-In for U.S. and Canada:

1-877-853-5642

Dial-In for International:

+1-253-237-1134

Conference call ID number:

50525720

Webcast link:

http://ir.hillenbrand.com (archived through Wednesday, March 5, 2014)



Replay - Conference Call

Date/Time:                       

Available until midnight EST, Wednesday, February 19, 2014

Dial-In for U.S. and Canada:

1-855-859-2056

Dial-In for International:

+1-404-537-3406

Conference call ID number:

50525720

Hillenbrand's interim financial statements on Form 10-Q are expected to be filed jointly with this release and will be available on the Company's website (www.Hillenbrand.com).

In addition to the financial measures prepared in accordance with accounting principles generally accepted in the U.S. (GAAP), this earnings release also contains non-GAAP operating performance measures. These non-GAAP measures are referred to as "adjusted" and exclude expenses associated with backlog amortization, inventory step-up, business acquisitions and integration, restructuring, and antitrust litigation. The related income tax for all of these items is also excluded. This non-GAAP information is provided as a supplement, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

An important non-GAAP measure Hillenbrand uses is adjusted earnings before interest, income tax, depreciation, and amortization ("adjusted EBITDA"). As previously discussed, a part of Hillenbrand's strategy is to selectively acquire companies that we believe can benefit from our core competencies to spur faster and more profitable growth. Given that strategy, it is a natural consequence to incur related expenses, such as amortization from acquired intangible assets and additional interest expense from debt-funded acquisitions. Accordingly, we use adjusted EBITDA, among other measures, to monitor business performance.

Hillenbrand uses this non-GAAP information internally to make operating decisions and believes it is helpful to investors because it allows more meaningful period-to-period comparisons of ongoing operating results. The information can also be used to perform trend analysis and to better identify operating trends that may otherwise be masked or distorted by these types of items. Finally, Hillenbrand believes this information provides a higher degree of transparency.

See below for a reconciliation from GAAP operating performance measures to the relevant non-GAAP (adjusted) performance measures. 

Hillenbrand (www.Hillenbrand.com) is a global diversified industrial company that makes and sells premium business-to-business products and services for a wide variety of industries. We pursue profitable growth and meaningful dividends for our shareholders by leveraging our leading brands, robust cash generation capabilities, and strong core competencies. HI-INC-F

 


Consolidated Statements of Income
(in millions, except per share data)








Three Months Ended




December 31,




2013



2012











Net revenue


$

384.9



$

305.2


Cost of goods sold



253.9




194.7


       Gross profit



131.0




110.5


Operating expenses



94.0




86.4


       Operating profit



37.0




24.1


Interest expense



6.3




4.5


Other income (expense), net



(0.1)




0.9


       Income before income taxes



30.6




20.5


Income tax expense



9.0




5.9


      Consolidated net income



21.6




14.6


Less: Net income attributable to noncontrolling interests



1.3




0.3


     Net income1


$

20.3



$

14.3











Net income1 per share of common stock:









Basic earnings per share


$

0.32



$

0.23


Diluted earnings per share


$

0.32



$

0.23


Weighted-average shares outstanding — basic



63.1




62.4


Weighted-average shares outstanding — diluted



63.7




62.6











Cash dividends per share


$

0.1975



$

0.1950











1Net income attributable to Hillenbrand









 

Condensed Consolidated Statements of Cash Flow
(in millions)






Three Months Ended

December 31,




2013



2012


Net cash provided by operating activities


$

45.9



$

19.7


Net cash used in investing activities



(6.2)




(418.6)


Net cash (used in) provided by financing activities



(19.3)




480.0


Effect of exchange rate changes on cash and cash equivalents



(0.8)




0.8


Net cash flow



19.6




81.9











Cash and cash equivalents:









At beginning of period



42.7




20.2


At end of period


$

62.3



$

102.1











 



Reconciliation of Non-GAAP Measures
(in millions, except per share data)




Three Months Ended December 31,



2013


2012



GAAP


Adjustments


Adjusted


GAAP


Adjustments


Adjusted

Cost of goods sold


$

253.9


$

(0.1) (a)


$

253.8


$

194.7


$

(3.0) (d)


$

191.7

Operating expenses



94.0



(2.1) (b)



91.9



86.4



(13.6) (e)



72.8

Other income

(expense), net



(0.1)





(0.1)



0.9



 

(0.9) (f)



Income tax expense



9.0



0.6 (c)



9.6



5.9



4.2 (c)



10.1

Net income1



20.3



1.6



21.9



14.3



11.5



25.8

Diluted EPS



0.32



0.02



0.34



0.23



0.18



0.41




















Ratios:



















Gross margin



34.0%



0.1%



34.1%



36.2%



1.0%



37.2%

Operating expenses

as a % of revenue



24.4%



(0.5)%



23.9%



28.3%



(4.4)%



23.9%


Both GAAP and adjusted results for the three months ended December 31, 2013, include an adjustment to operating expenses to correct errors related to the accounting for sales commissions at Coperion in fiscal 2013.  The adjustment reduced operating expenses in the first quarter of fiscal 2014 by $2.0, which should have been recorded in fiscal 2013.





1 Net income attributable to Hillenbrand





P = Process Equipment Group; B = Batesville; C = Corporate


(a) Restructuring ($0.1 B)


(b) Business acquisition and integration costs ($0.7 P, $1.2 C), restructuring ($0.2 P)


(c) Tax effect of adjustments


(d) Inventory step up ($2.6 P), restructuring ($0.1 P, $0.3 B)


(e) Business acquisition and integration costs ($9.0 C), backlog amortization ($4.2 P), restructuring ($0.2 C),

antitrust litigation ($0.1 B), other ($0.1 B)


(f) Acquisition-related foreign currency transactions ($0.8 C), other ($0.1 B)

























 





Three Months Ended

December 31,






2013



2012


Net income of consolidated and affiliated









subsidiaries


$

21.6



$

14.6


Interest income



(0.2)




(0.1)


Interest expense



6.3




4.5


Income tax expense



9.0




5.9


Depreciation and amortization



14.3




15.0


EBITDA


$

51.0



$

39.9


Business acquisition and integration



1.9




8.2


Inventory step-up






2.6


Restructuring



0.3




0.6


Antitrust litigation






0.1


EBITDA – adjusted


$

53.2



$

51.4











 

Throughout this release, we make a number of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. As the words imply, forward-looking statements are statements about the future, as contrasted with historical information. Our forward-looking statements are based on assumptions and current expectations of future events that we believe are reasonable, but by their very nature they are subject to a wide range of risks. If our assumptions prove inaccurate or unknown risks and uncertainties materialize, actual results could vary materially from Hillenbrand's expectations and projections.

Words that could indicate that we are making forward-looking statements include the following:

intend

believe

plan

expect

may

goal

would

become

pursue

estimate

will

forecast

continue

could

targeted

encourage

promise

improve

progress

potential

should

This is not an exhaustive list. Our intent is to provide examples of how readers might identify forward-looking statements. The absence of any of these words, however, does not mean that the statement is not forward-looking.

Here is the key point: Forward-looking statements are not guarantees of future performance, and our actual results could differ materially from those set forth in any forward-looking statements. Any number of factors, many of which are beyond our control, could cause our performance to differ significantly from what is described in the forward-looking statements. These factors include, but are not limited to: the outcome of any legal proceedings that may be instituted against Hillenbrand, or any companies we may acquire; risks that an acquisition disrupts current operations or poses potential difficulties in employee retention or otherwise affects financial or operating results; the ability to recognize the benefits of an acquisition, including potential synergies and cost savings or the failure of an acquired company to achieve its plans and objectives generally; global market and economic conditions, including those related to the credit markets; volatility of our investment portfolio; adverse foreign currency fluctuations; ongoing involvement in claims, lawsuits and governmental proceedings related to operations; labor disruptions; the dependence of our business units on relationships with several large providers; increased costs or unavailability of raw materials; continued fluctuations in mortality rates and increased cremations; competition from nontraditional sources in the death care industry; cyclical demand for industrial capital goods; and certain tax-related matters. For a more in-depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in Part II, Item 1A of Hillenbrand's Form 10-Q for the quarter ended December 31, 2013, filed with the Securities and Exchange Commission on February 4, 2014. The company assumes no obligation to update or revise any forward-looking information.

SOURCE Hillenbrand, Inc.

CONTACT: Chris Gordon, Director, Investor Relations, Phone: 812-931-5001, Email: chris.gordon@hillenbrand.com